PLX icon

Protalix BioTherapeutics

30 hedge funds and large institutions have $2.44M invested in Protalix BioTherapeutics in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 11 closing their positions.

Holders
30
Holders Change
-4
Holders Change %
-11.76%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
7
Reduced
10
Closed
11
Calls
$140K
Puts
$614K
Net Calls
-$474K
Net Calls Change
-$628K
Name Holding Trade Value Shares
Change
Shares
Change %
MIH
26
Meitav Investment House
Israel
-$325K -244,332 Closed
Walleye Capital
27
Walleye Capital
New York
-$293 -220,089 Closed
Walleye Trading
28
Walleye Trading
New York
-$108K -81,000 Closed
Simplex Trading
29
Simplex Trading
Illinois
-$129K -69,049 Closed
BCM
30
Bridgeway Capital Management
Texas
-$78K -58,890 Closed
CS
31
Credit Suisse
Switzerland
-$43K -31,974 Closed
Wolverine Trading
32
Wolverine Trading
Illinois
-$39K -28,168 Closed
XT
33
XTX Topco
Cayman Islands
-$27K -20,514 Closed
JPMorgan Chase & Co
34
JPMorgan Chase & Co
New York
-$8K -5,847 Closed
HI
35
Harbour Investments
Wisconsin
-$4K -3,000 Closed
SPIA
36
Steward Partners Investment Advisory
New York
-$1K -1,000 Closed